Benedikt Rauscher

Benedikt Rauscher is a seasoned bioinformatics professional with extensive experience in benefit-risk analytics and research within the fields of genomics and molecular biology. Currently serving as the Benefit-Risk Analytics Lead and Benefit-Risk Strategy Expert at Merck Group since March 2022, Benedikt has previously held roles as a Visiting Research Scientist and Postdoctoral Researcher at EMBL, focusing on CRISPR screens and computational pipeline development. Benedikt's doctoral research at DKFZ German Cancer Research Center involved creating a statistical framework to integrate genomic datasets and predict synthetic lethal gene pairs. Additional experience includes work as a Visiting Scientist at The Genome Analysis Centre and as a Research Assistant at Ludwig-Maximilians Universität München. Benedikt holds a PhD in Bioinformatics from Heidelberg University, a Master’s degree from Technical University of Munich, and a Bachelor’s degree from the same institution.